ENTRY       D00775                      Drug
NAME        Riluzole (JAN/USP/INN);
            Rilutek (TN)
PRODUCT     EXSERVAN (Mitsubishi Tanabe Pharma America)
            RILUTEK (Covis Pharma US)
            TIGLUTIK (Itf Pharma)
  GENERIC   RILUZOLE (Ascend Laboratories)
            RILUZOLE (AvKARE)
            RILUZOLE (Glenmark Pharmaceuticals)
            RILUZOLE (Mylan Pharmaceuticals)
            RILUZOLE (Quinn Pharmaceuticals)
            RILUZOLE (Sun Pharmaceutical Industries)
FORMULA     C8H5F3N2OS
EXACT_MASS  234.0075
MOL_WEIGHT  234.1983
CLASS       Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
REMARK      Same as: C07937
            Therapeutic category: 1190
            ATC code: N07XX02
            Product: D00775<JP/US>
EFFICACY    Nerve cells protectant
  DISEASE   Amyotrophic lateral sclerosis [DS:H00058]
COMMENT     Amyotrophic lateral sclerosis treatment
TARGET      GRIN (NMDAR) [HSA:2902 2903 2904 2905 2906] [KO:K05208 K05209 K05210 K05211 K05212]
            GRIA [HSA:2890 2891 2892 2893] [KO:K05197 K05198 K05199 K05200]
            GRIK [HSA:2897 2898 2899 2900 2901] [KO:K05201 K05202 K05203 K05204 K05205]
  PATHWAY   hsa04080(2890+2891+2892+2893+2897+2898+2899+2900+2901+2902+2903+2904+2905+2906)  Neuroactive ligand-receptor interaction
            hsa04724(2890+2891+2892+2893+2897+2898+2899+2900+2901+2902+2903+2904+2905+2906)  Glutamatergic synapse
            hsa04728(2890+2891+2892+2893+2903+2904)  Dopaminergic synapse
            hsa05014(2890+2891+2902+2903+2904+2905+2906)  Amyotrophic lateral sclerosis
METABOLISM  Enzyme: CYP1A2 [HSA:1544]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07X OTHER NERVOUS SYSTEM DRUGS
                N07XX Other nervous system drugs
                 N07XX02 Riluzole
                  D00775  Riluzole (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Central Nervous System Agents
              Amyotrophic Lateral Sclerosis (ALS) Agents
               Riluzole
                D00775  Riluzole (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               119  Miscellaneous
                1190  Miscellaneous
                 D00775  Riluzole (JAN/USP/INN)
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               D00775  Riluzole
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Ligand-gated ion channels
               Glutamate (ionotropic), non-NMDA
                GRIA
                 D00775  Riluzole (JAN/USP/INN) &lt;JP/US&gt;
                GRIK
                 D00775  Riluzole (JAN/USP/INN) &lt;JP/US&gt;
               Glutamate (ionotropic), NMDA
                GRIN (NMDAR)
                 D00775  Riluzole (JAN/USP/INN) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00775
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00775
DBLINKS     CAS: 1744-22-5
            PubChem: 7847840
            ChEBI: 8863
            PDB-CCD: 657
            LigandBox: D00775
            NIKKAJI: J22.921K
ATOM        15
            1   C1d C    22.1906  -18.2535
            2   O2a O    23.4014  -17.5492
            3   X   F    20.9739  -17.5492
            4   X   F    22.1849  -19.6507
            5   X   F    20.9739  -18.9405
            6   C8y C    24.6065  -18.2535
            7   C8x C    25.8233  -17.5492
            8   C8x C    24.6065  -19.6507
            9   C8y C    27.0284  -18.2478
            10  C8x C    25.8233  -20.3494
            11  C8y C    27.0343  -19.6507
            12  S2x S    28.3616  -17.8053
            13  N5x N    28.3733  -20.0757
            14  C8y C    29.1882  -18.9346
            15  N1a N    30.5797  -18.8705
BOND        16
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 1
            5     2   6 1
            6     6   7 2
            7     6   8 1
            8     7   9 1
            9     8  10 2
            10    9  11 2
            11    9  12 1
            12   11  13 1
            13   12  14 1
            14   14  15 1
            15   10  11 1
            16   13  14 2
///
